Cited by 2,472COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchImmune cells in cancer

The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.

Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages

Open access

Merad, Miriam, Martin, Jerome C.·2020·Nature Reviews Immunology

DOI 10.1038/s41577-020-0331-4PMC PMC7201395

Open this paper in CoChat — free account Open PDF

Abstract

The COVID-19 pandemic caused by infection with SARS-CoV-2 has led to more than 200,000 deaths worldwide. Several studies have now established that the hyperinflammatory response induced by SARS-CoV-2 is a major cause of disease severity and death in infected patients. Macrophages are a population of innate immune cells that sense and respond to microbial threats by producing inflammatory molecules that eliminate pathogens and promote tissue repair. However, a dysregulated macrophage response can be damaging to the host, as is seen in the macrophage activation syndrome induced by severe infections, including in infections with the related virus SARS-CoV. Here we describe the potentially pathological roles of macrophages during SARS-CoV-2 infection and discuss ongoing and prospective therapeutic strategies to modulate macrophage activation in patients with COVID-19.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41577-020-0331-4

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: a descriptive study.
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
COVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664
Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area
Richardson, S., Hirsch, J. S., Narasimhan, M., Crawford, J. M., McGinn, T., Davidson, K. W., and the Northwell COVID-19 Research Consortium, Barnaby, D. P., Becker, L. B., Chelico, J. D., et al. (2020) · JAMA · doi:10.1001/jama.2020.6775 · Cited by 9,254
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.0994 · Cited by 8,249
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis
Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
Ruan, Q., Yang, K., Wang, W., Jiang, L., & Song, J. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05991-x · Cited by 4,898

Show all 65 references

Sorted by citations

Items 701–800 of 1,002

Anti-Granulocyte–Macrophage Colony–Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial
Criner, G. J., Lang, F. M., Gottlieb, R., Mathews, K. S., Wang, T. S., Rice, T. W., Madduri, D., Bellam, S., Jeanfreau, R., Case, A. H., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202108-1859oc · Cited by 32
Prior Vaccination Exceeds Prior Infection in Eliciting Innate and Humoral Immune Responses in Omicron Infected Outpatients
Lee, H., Knabl, L., Walter, M. F., Knabl, L., Dai, Y., Füßl, M., Caf, Y., Jeller, C., Knabl, P., Obermoser, M., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.916686 · Cited by 32
Role of Innate and Adaptive Cytokines in the Survival of COVID-19 Patients
Monserrat, J., Gomez-Lahoz, A. M., Ortega, M. A., Sanz, J., Muñoz, B., Arévalo‐Serrano, J., González-Moro, J. M. R., Gasalla-Herraiz, J., Gasulla, Ó., Arranz, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810344 · Cited by 31
Synthesis and Anti-Inflammatory Activity Evaluation of Some Benzimidazole Derivatives
Moharana, A. K., Dash, R. N., Mahanandia, N. C., & Subudhi, B. B. (2022) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-022-02755-3 · Cited by 31
Gut Microbiota Dysbiosis in COVID-19: Modulation and Approaches for Prevention and Therapy
Giménez, V. M. M., Modrego, J., Gómez‐Garré, D., Manucha, W. A., & Heras, N. D. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512249 · Cited by 31
Robust cross-cohort gut microbiome associations with COVID-19 severity
Li, J., Ghosh, T. S., MacCann, R., Mallon, P. W. G., Hill, C., Draper, L. A., Schult, D., Fanning, L. J., Shannon, R., Sadlier, C., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2242615 · Cited by 32
SARS-CoV-2 spike protein induces abnormal inflammatory blood clots neutralized by fibrin immunotherapyPreprint
Ryu, J. K., Sözmen, E. G., Dixit, K., Montaño, M., Matsui, Y., Liu, Y., Helmy, E. W., Deerinck, T. J., Yan, Z., Schuck, R., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.12.464152 · Cited by 33
Multimodal single-cell omics analysis identifies epithelium–immune cell interactions and immune vulnerability associated with sex differences in COVID-19
Hou, Y., Zhou, Y., Gack, M. U., Lathia, J. D., Kallianpur, A. R., Mehra, R., Chan, T. A.-T., Jung, J. U., Jehi, L. E., Eng, C., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00709-x · Cited by 32
Trimannose-coupled antimiR-21 for macrophage-targeted inhalation treatment of acute inflammatory lung damage
Beck, C., Ramanujam, D. P., Vaccarello, P., Widenmeyer, F., Feuerherd, M., Cheng, C., Bomhard, A., Abikeeva, T., Schädler, J., Sperhake, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40185-1 · Cited by 30
Peripheral immune landscape for hypercytokinemia in myasthenic crisis utilizing single-cell transcriptomics
Zhong, H., Huan, X., Zhao, R., Su, M., Yan, C., Song, J., Xi, J., Zhao, C., Luo, F.-F., & Luo, S.-S. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04421-y · Cited by 28
Virus-Induced Acute Respiratory Distress Syndrome Causes Cardiomyopathy Through Eliciting Inflammatory Responses in the Heart
Grune, J., Bajpai, G., Ocak, P. T., Kaufmann, E., Mentkowski, K. I., Pabel, S., Kumowski, N., Pulous, F. E., Tran, K. A., Rohde, D., et al. (2024) · Circulation · doi:10.1161/circulationaha.123.066433 · Cited by 31
Inflammation and thrombosis in patients with COVID-19: a prothrombotic and inflammatory disease caused by SARS Coronavirus-2
Pamukçu, B. (2020) · The Anatolian Journal of Cardiology · doi:10.14744/anatoljcardiol.2020.56727 · Cited by 30
In silico Analyses of Immune System Protein Interactome Network, Single-Cell RNA Sequencing of Human Tissues, and Artificial Neural Networks Reveal Potential Therapeutic Targets for Drug Repurposing Against COVID-19
López‐Cortés, A., Guevara‐Ramírez, P., Kyriakidis, N. C., Barba‐Ostria, C., Cáceres, Á. L., Guerrero, S. X., Ortiz‐Prado, E., Munteanu, C. R., Tejera, E., Cevallos-Robalino, D., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.598925 · Cited by 30
SARS-CoV-2 morbidity and mortality in racial/ethnic minority populations: A window into the stress related inflammatory basis of health disparities?
Gelaye, B., Foster, S. L., Bhasin, M., Tawakol, A. A., & Fricchione, G. L. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100158 · Cited by 32
The role of kallikrein-kinin and renin-angiotensin systems in COVID-19 infection
de Carvalho, P. R., Sirois, P., & Fernandes, P. D. (2020) · Peptides · doi:10.1016/j.peptides.2020.170428 · Cited by 32
Transcriptional Changes in CD16+ Monocytes May Contribute to the Pathogenesis of COVID-19
Chilunda, V., Martínez-Aguado, P., Xia, L. C., Cheney, L., Murphy, A., Veksler, V., Ruiz, V. Y., Calderon, T. M., & Berman, J. W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.665773 · Cited by 29
Aneurysmal Subarachnoid Hemorrhage in Patients with Coronavirus Disease 2019 (COVID-19): A Case Series
Dodd, W., Jabbour, P. M., Sweid, A., Tjoumakaris, S. I., Gooch, M. R., Saiegh, F. A., Hasan, D. M., Starke, R. M., Kan, P. T. M., Polifka, A. J., et al. (2021) · World Neurosurgery · doi:10.1016/j.wneu.2021.06.092 · Cited by 30
The relationship between Dietary Inflammatory Index and disease severity and inflammatory status: a case–control study of COVID-19 patients
Moludi, J., Qaisar, S. A., Alizadeh, M., Vayghan, H. J., Naemi, M., Rahimi, A., & Mousavi, R. (2021) · British Journal Of Nutrition · doi:10.1017/s0007114521003214 · Cited by 30
Aging whole blood transcriptome reveals candidate genes for SARS-CoV-2-related vascular and immune alterations
Chuffa, L. G. D. A., Freire, P. P., Souza, J. D. S., de Mello, M. C., Neto, M. D. O., & Carvalho, R. F. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-021-02161-4 · Cited by 29
Immunomodulatory agents for COVID-19 treatment: possible mechanism of action and immunopathology features
Rommasi, F., Nasiri, M. J., & Mirsaeidi, M. S. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04325-9 · Cited by 31
Antioxidant/anti‐inflammatory effect of Mg2+ in coronavirus disease 2019 (COVID‐19)
Arancibia‐Hernández, Y. L., Aranda‐Rivera, A. K., Cruz‐Gregorio, A., & Pedraza‐Chaverrí, J. (2022) · Reviews in Medical Virology · doi:10.1002/rmv.2348 · Cited by 30
Protection by metformin against severe Covid-19: An in-depth mechanistic analysis
Wiernsperger, N. F., Al‐Salameh, A., Cariou, B., & Lalau, J. (2022) · Diabetes & Metabolism · doi:10.1016/j.diabet.2022.101359 · Cited by 31
Rationale of using the dual chemokine receptor CCR2/CCR5 inhibitor cenicriviroc for the treatment of COVID-19
Files, D. C., Tacke, F., O’Sullivan, A., Dorr, P. K., Ferguson, W., & Powderly, W. G. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010547 · Cited by 29
Interplay of LncRNAs NEAT1 and TUG1 in Incidence of Cytokine Storm in Appraisal of COVID-19 Infection
Tayel, S. I., El-Masry, E. A., Abdelaal, G. A., Shehab-Eldeen, S., Essa, A. S., & Muharram, N. M. M. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.72318 · Cited by 30
Astrocytes and the Psychiatric Sequelae of COVID-19: What We Learned from the Pandemic
Steardo, L., Steardo, L., & Scuderi, C. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03709-7 · Cited by 34
SARS-CoV-2 S protein activates NLRP3 inflammasome and deregulates coagulation factors in endothelial and immune cells
Villacampa, A., Alfaro, E., Morales, C., Díaz‐García, E., López-Fernández, C., Bartha, J. L., López-Sánchez, F., Lorenzo, Ó., Moncada, S., Sánchez‐Ferrer, C. F., et al. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01397-6 · Cited by 34
Pulmonary macrophages and SARS-Cov2 infection
Bain, C. C., Lucas, C. D., & Rossi, A. G. (2022) · International review of cytology · doi:10.1016/bs.ircmb.2022.01.001 · Cited by 31
The potential mechanism of Isodon suzhouensis against COVID-19 via EGFR/TLR4 pathways
Duan, H., Wang, W., Li, S., Han, L., Khan, G. J., Ma, Y., Liu, F., Zhai, K., Hu, H., & Wei, Z. (2024) · Food Science and Human Wellness · doi:10.26599/fshw.2023.9250011 · Cited by 29
The “cytokine storm” in infection and sepsis: win the battle but lose the war
Fan, J., Li, Q.-Y., Feng, X.-F., Huang, S., Wang, R., Liao, F.-Y., Liu, D., Liu, W.-Y., Sun, J.-H., Zhang, H.-C., et al. (2026) · Military Medical Research · doi:10.1186/s40779-025-00678-0 · Cited by 35
Are All Patients with Cancer at Heightened Risk for Severe Coronavirus Disease 2019 (COVID-19)?
Chamilos, G., Lionakis, M. S., & Kontoyiannis, D. P. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1079 · Cited by 29
The Collision of Meta-Inflammation and SARS-CoV-2 Pandemic Infection
Huizinga, G. P., Singer, B. H., & Singer, K. (2020) · Endocrinology · doi:10.1210/endocr/bqaa154 · Cited by 28
Mitigating Coronavirus Induced Dysfunctional Immunity for At-Risk Populations in COVID-19: Trained Immunity, BCG and “New Old Friends”
Kleen, T. O., Galdon, A. A., MacDonald, A. S., & Dalgleish, A. G. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02059 · Cited by 29
Shorter incubation period is associated with severe disease progression in patients with COVID-19
Lai, C., Yu, R., Wang, M., Xian, W., Zhao, X., Tang, Q., Chen, R., Zhou, X., Li, X., Li, Z., et al. (2020) · Virulence · doi:10.1080/21505594.2020.1836894 · Cited by 28
COVID-19 Pandemic: Oral Health Challenges and Recommendations
Farook, F. F., Nuzaim, M. N. M., Ababneh, K. T., Alshammari, A., & Alkadi, L. (2020) · European Journal of Dentistry · doi:10.1055/s-0040-1718641 · Cited by 30
Neopterin: A Promising Candidate Biomarker for Severe COVID-19
Hailemichael, W., Kiros, M., Akelew, Y., Getu, S., & Henok, A. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s290264 · Cited by 29
Infection, inflammation and intervention: mechanistic modelling of epithelial cells in COVID-19
Fadai, N. T., Sachak-Patwa, R., Byrne, H. M., Maini, P. K., Bafadhel, M., & Nicolau, D. V. (2021) · Journal of The Royal Society Interface · doi:10.1098/rsif.2020.0950 · Cited by 29
Interpretation of Hematological, Biochemical, and Immunological Findings of COVID-19 Disease: Biomarkers Associated with Severity and Mortality
Ghazanfari, T., Salehi, M. R., Namaki, S., Arabkheradmand, J., Rostamian, A., Chenary, M. R., Ghaffarpour, S., Ardestani, S. K., Edalatifard, M., Naghizadeh, M. M., et al. (2021) · Iranian Journal of Allergy Asthma and Immunology · doi:10.18502/ijaai.v20i1.5412 · Cited by 30
COVID-19 as a mediator of interferon deficiency and hyperinflammation: Rationale for the use of JAK1/2 inhibitors in combination with interferon
Hasselbalch, H. C., Skov, V., Kjær, L., Ellervik, C., Poulsen, A., Poulsen, T. D., & Nielsen, C. H. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2021.03.006 · Cited by 30
Targeting of the CD80/86 proinflammatory axis as a therapeutic strategy to prevent severe COVID-19
Julià, A., Bonafonte-Pardàs, I., Gómez, A., Lasanta, M. L., López-Corbeto, M., Martínez-Mateu, S. H., Lladós, J., Rodríguez-Nunez, I., Myers, R., & Marsal, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-90797-0 · Cited by 30
Lupus, vaccinations and COVID-19: What we know now
Mason, A., Anver, H., Lwin, M., Holroyd, C. R., Faust, S. N., & Edwards, C. J. (2021) · Lupus · doi:10.1177/09612033211024355 · Cited by 29
High Prevalence of Anti-PF4 Antibodies Following ChAdOx1 nCov-19 (AZD1222) Vaccination Even in the Absence of Thrombotic Events
Terpos, E., Politou, M., Ntanasis‐Stathopoulos, I., Karalis, V. D., Merkouri, E., Fotiou, D., Gavriatopoulou, M., Malandrakis, P., Kastritis, E., Trougakos, I. P., et al. (2021) · Vaccines · doi:10.3390/vaccines9070712 · Cited by 28
Safety and efficacy of a COVID‑19 treatment with nebulized and/or intravenous neutral electrolyzed saline combined with usual medical care vs. usual medical care alone: A randomized, open‑label, controlled trial
Delgado‐Enciso, I., Paz-García, J., Barajas-Saucedo, C. E., Mokay-Ramírez, K. A., Meza‐Robles, C., Lopez‐Flores, R., Delgado‐Machuca, M., Murillo‐Zamora, E., Toscano-Velazquez, J. A., Delgado‐Enciso, J., et al. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10347 · Cited by 29
Inflammatory Response in COVID-19 Patients Resulting from the Interaction of the Inflammasome and SARS-CoV-2
Cheon, S. Y., & Koo, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157914 · Cited by 34
Determinants and Dynamics of SARS-CoV-2 Infection in a Diverse Population: 6-Month Evaluation of a Prospective Cohort Study
Horton, D. B., Barrett, E. S., Roy, J., Gennaro, M. L., Andrews, T., Greenberg, P. J., Bruiners, N., Datta, P., Ukey, R., Velusamy, S. K., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab411 · Cited by 28
Low 25(OH)D Level Is Associated with Severe Course and Poor Prognosis in COVID-19
Каронова, Т. Л., Тимуровна, А. А., Golovatyuk, K. A., Bykova, E. S., Симаненкова, А. В., Vashukova, M. A., Grant, W. B., & Shlyakhto, E. V. (2021) · Nutrients · doi:10.3390/nu13093021 · Cited by 29
A Deep Look Into COVID-19 Severity Through Dynamic Changes in Blood Cytokine Levels
Kleymenov, D. A., Bykonia, E. N., Popova, L. I., Mazunina, E. P., Gushchin, V. А., Колобухина, Л. В., Burgasova, O., Kruzhkova, I. S., Kuznetsova, N. A., Shidlovskaya, E. V., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.771609 · Cited by 30
The inflammatory biomarkers profile of hospitalized patients with COVID-19 and its association with patient’s outcome: A single centered study
Hachim, I. Y., Hachim, M. Y., Hannawi, H., Naeem, K., Salah, A., & Hannawi, S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0260537 · Cited by 29
Procalcitonin Increase Is Associated with the Development of Critical Care-Acquired Infections in COVID-19 ARDS
Richards, O., Pallmann, P., King, C., Cheema, Y., Killick, C., Thomas‐Jones, E., Harris, J., Bailey, C., & Szakmány, T. (2021) · Antibiotics · doi:10.3390/antibiotics10111425 · Cited by 30
Explainable Artificial Intelligence for COVID-19 Diagnosis Through Blood Test Variables
Thimoteo, L. M., Vellasco, M. M. B. R., Amaral, J. L. M., Figueiredo, K., Yokoyama, C. L., & Marques, E. (2022) · Journal of Control Automation and Electrical Systems · doi:10.1007/s40313-021-00858-y · Cited by 31
Monocytes as a convergent nanoparticle therapeutic target for cardiovascular diseases
Aldarondo, D., & Wayne, E. C. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114116 · Cited by 28
VIP plasma levels associate with survival in severe COVID-19 patients, correlating with protective effects in SARS-CoV-2-infected cells
Temerozo, J. R., Sacramento, C. Q., Rodrigues, N. F., Pão, C. R. R., de Freitas, C. S., Dias, S. D. S. G., Ferreira, A. C., Mattos, M., Soares, V. C., Teixeira, L., et al. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.5cova1121-626r · Cited by 30
High-CBD Extract (CBD-X) Downregulates Cytokine Storm Systemically and Locally in Inflamed Lungs
Aswad, M., Hamza, H., Pechkovsky, A., Zikrach, A., Popov, T., Zohar, Y., Shahar, E., & Louria‐Hayon, I. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.875546 · Cited by 30
Beneficial Effect of Short-Term Supplementation of High Dose of Vitamin D3 in Hospitalized Patients With COVID-19: A Multicenter, Single-Blinded, Prospective Randomized Pilot Clinical Trial
Cervero, M., Wolf, D. L., Casado‐Fernández, G., Mena, M. N., Ryan, P., Martínez, M. L. T., Rodríguez-Mora, S., Vigón, L., Coiras, M., & Torres, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.863587 · Cited by 29
SARS-CoV-2 consequences for mental health: Neuroinflammatory pathways linking COVID-19 to anxiety and depression
de Mello, A. J., Moretti, M., & Rodrigues, A. L. S. (2022) · World Journal of Psychiatry · doi:10.5498/wjp.v12.i7.874 · Cited by 32
Coronavirus disease 2019 subphenotypes and differential treatment response to convalescent plasma in critically ill adults: secondary analyses of a randomized clinical trial
Fish, M., Rynne, J., Jennings, A. R., Lam, C., Lamikanra, A., Ratcliff, J., Trevelin, S. C., Timms, E. M., Jiriha, J., Tosi, I., et al. (2022) · Intensive Care Medicine · doi:10.1007/s00134-022-06869-w · Cited by 28
Lymphocyte–C-reactive protein ratio can differentiate disease severity of COVID-19 patients and serve as an assistant screening tool for hospital and ICU admission
Zhang, J., Gao, Y., Wang, X.-T., Li, N., Du, X., Tang, Y.-J., Lai, Q.-Q., Chen, P., Yue, C.-S., Wu, J.-H., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.957407 · Cited by 28
Immune phenotypes that are associated with subsequent COVID-19 severity inferred from post-recovery samples
Liechti, T., Iftikhar, Y., Mangino, M., Beddall, M. H., Goss, C. W., O’Halloran, J. A., Mudd, P. A., & Roederer, M. (2022) · Nature Communications · doi:10.1038/s41467-022-34638-2 · Cited by 32
Cannabinoid WIN55,212-2 reprograms monocytes and macrophages to inhibit LPS-induced inflammation
Pérez‐Diego, M., Angelina, A., Martín‐Cruz, L., de la Rocha‐Muñoz, A., Maldonado, A. E., Sevilla‐Ortega, C., & Palomares, Ó. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1147520 · Cited by 29
Selenium supplementation decreases CRP and IL-6 and increases TNF-alpha: A systematic review and meta-analysis of randomized controlled trials
Gholizadeh, M., Khalili, A., Roodi, P. B., Saeedy, S. A. G., Najafi, S., Mohammadian, M. K., & Djafarian, K. (2023) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2023.127199 · Cited by 29
Advancing cellular immunotherapy with macrophages
Mishra, A., & Malonia, S. K. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121857 · Cited by 29
Two distinct immunopathological profiles in autopsy lungs of COVID-19Preprint
Nienhold, R., Ciani, Y., Koelzer, V. H., Tzankov, A., Haslbauer, J. D., Menter, T., Schwab, N., Henkel, M. J., Frank, A., Zsikla, V., et al. (2020) · medRxiv · doi:10.1101/2020.06.17.20133637 · Cited by 29
A transcriptome-based human universal senescence index (hUSI) robustly predicts cellular senescence under various conditions
Wang, J., Zhou, X., Yu, P., Yao, J., Guo, P., Xu, Q., Zhao, Y., Wang, G., Li, Q., Zhu, X., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00886-2 · Cited by 28
Immunostimulant and Antidepressant Effect of Natural Compounds in the Management of Covid-19 Symptoms
Alesci, A., Fumia, A., Cascio, P. L., Miller, A., & Cicero, N. (2021) · Journal of the American Nutrition Association · doi:10.1080/07315724.2021.1965503 · Cited by 28
Organoids in virology
Chu, J. T. S., & Lamers, M. M. (2024) · npj Viruses · doi:10.1038/s44298-024-00017-5 · Cited by 31
Linking ACE2 and angiotensin II to pulmonary immunovascular dysregulation in SARS-CoV-2 infection
Seltzer, S. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.09.041 · Cited by 28
Elevated markers of thrombo-inflammatory activation predict outcome in patients with cardiovascular comorbidities and COVID-19 disease: insights from the LEOSS registry
Cremer, S., Jakob, C. E. M., Berkowitsch, A., Borgmann, S., Pilgram, L., Tometten, L., Classen, A. Y., Wille, K., Weidlich, S., Gruener, B., et al. (2020) · Clinical Research in Cardiology · doi:10.1007/s00392-020-01769-9 · Cited by 28
Comparison of different anticoagulation strategies for renal replacement therapy in critically ill patients with COVID-19: a cohort study
Arnold, F., Westermann, L., Rieg, S., Neumann‐Haefelin, E., Biever, P. M., Walz, G., Kalbhenn, J., & Tanriver, Y. (2020) · BMC Nephrology · doi:10.1186/s12882-020-02150-8 · Cited by 28
Current understanding of the impact of COVID-19 on gastrointestinal disease: Challenges and openings
Sahu, T. A., Mehta, A., Ratre, Y. K., Jaiswal, A., Vishvakarma, N. K., Bhaskar, L. V., & Verma, H. K. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i6.449 · Cited by 28
Specialized Pro-Resolving Mediators as Potential Regulators of Inflammatory Macrophage Responses in COVID-19
Balta, M. G., Papathanasiou, E., & CHRISTOPOULOS, P. F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.632238 · Cited by 28
Biomaterial-based immunoengineering to fight COVID-19 and infectious diseases
Zarubova, J., Zhang, X., Hoffman, T., Hasani‐Sadrabadi, M. M., & Li, S. (2021) · Matter · doi:10.1016/j.matt.2021.02.025 · Cited by 28
Abnormal upregulation of cardiovascular disease biomarker PLA2G7 induced by proinflammatory macrophages in COVID-19 patients
Yang, L., Jiang, Y., Zhang, Y., Li, N., Yin, Q., Liu, L., Lv, X., Liu, Y., Li, A., Fang, B., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-85848-5 · Cited by 28
Sex-specific impact of severe obesity in the outcomes of hospitalized patients with COVID-19: a large retrospective study from the Bronx, New York
Guerson-Gil, A., Palaiodimos, L., Assa, A., Karamanis, D., Kokkinidis, D. G., Chamorro-Pareja, N., Kishore, P., Leider, J. M., & Brandt, L. J. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-021-04260-z · Cited by 30
The effect of estrogen in coronavirus disease 2019
Ma, Q., Hao, Z., & Wang, Y. (2021) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00332.2020 · Cited by 29
Comparative Immunomodulatory Evaluation of the Receptor Binding Domain of the SARS-CoV-2 Spike Protein; a Potential Vaccine Candidate Which Imparts Potent Humoral and Th1 Type Immune Response in a Mouse Model
Shrivastava, T., Singh, B., Rizvi, Z. A., Verma, R., Goswami, S., Vishwakarma, P., Jakhar, K., Sonar, S., Mani, S., Bhattacharyya, S., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.641447 · Cited by 26
Wharton's Jelly Mesenchymal Stem Cell-Derived Extracellular Vesicles Reduce SARS-CoV2-Induced Inflammatory Cytokines Under High Glucose and Uremic Toxin Conditions
Khánh, V. C., Fukushige, M., Chang, Y. H., Hoang, N. N., Yamashita, T., Obata‐Yasuoka, M., Hamada, H., Osaka, M., Hiramatsu, Y., & Ohneda, O. (2021) · Stem Cells and Development · doi:10.1089/scd.2021.0065 · Cited by 28
MicroRNA-223 modulates the IL-4-medicated macrophage M2-type polarization to control the progress of sepsis
Wang, X., Zhang, H., Guo, R., Li, X., Liu, H., Wang, Z., Du, Q., Tong, D., & Huang, Y. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107783 · Cited by 28
Pathological effects of SARS-CoV-2 on hematological and immunological cells: Alterations in count, morphology, and function
Ahmadi, E., Bagherpour, Z., Zarei, E., & Omidkhoda, A. (2022) · Pathology - Research and Practice · doi:10.1016/j.prp.2022.153782 · Cited by 29
Neuropilin‐1‐Mediated SARS‐CoV‐2 Infection in Bone Marrow‐Derived Macrophages Inhibits Osteoclast Differentiation
Gao, J., Mei, H., Sun, J., Li, H., Huang, Y., Tang, Y., Duan, L., Liu, D., Pang, Y., Wang, Q., et al. (2022) · Advanced Biology · doi:10.1002/adbi.202200007 · Cited by 28
Korean Red Ginseng, a regulator of NLRP3 inflammasome, in the COVID-19 pandemic
Jung, E., & Lee, G. (2022) · Journal of Ginseng Research · doi:10.1016/j.jgr.2022.02.003 · Cited by 28
Serum extracellular vesicles profiling is associated with COVID‐19 progression and immune responses
Yim, K. H. W., Borgoni, S., & Chahwan, R. (2022) · Journal of Extracellular Biology · doi:10.1002/jex2.37 · Cited by 28
High dose melatonin as an adjuvant therapy in intubated patients with COVID-19: A randomized clinical trial
Alizadeh, N. S., Dianatkhah, M., Alimohamadi, Y., Moradi, H., Akbarpour, S., Akrami, M., Mansouri, F., Faraji, N., Rezaie, Z., Alizadeh, M., et al. (2022) · Journal of Taibah University Medical Sciences · doi:10.1016/j.jtumed.2022.04.012 · Cited by 26
Possible Role of Matrix Metalloproteinases and TGF-β in COVID-19 Severity and Sequelae
Ramírez-Martínez, G., Jiménez-Álvarez, L. A., Cruz‐Lagunas, A., Ignacio-Cortés, S., Gómez-García, I. A., Rodríguez-Reyna, T. S., Choreño-Parra, J. A., & Zúñiga, J. (2022) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2021.0222 · Cited by 29
Comparing the Cytokine Storms of COVID-19 and Pandemic Influenza
Pacheco-Hernández, L. M., Ramírez-Noyola, J. A., Gómez-García, I. A., Ignacio-Cortés, S., Zúñiga, J., & Choreño-Parra, J. A. (2022) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2022.0029 · Cited by 29
H1N1 influenza virus dose dependent induction of dysregulated innate immune responses and STAT1/3 activation are associated with pulmonary immunopathological damage
Yao, D., Bao, L., Li, F., Liu, B., Wu, X., Hu, Z., Xu, J., Wang, W., & Zhang, X. (2022) · Virulence · doi:10.1080/21505594.2022.2120951 · Cited by 28
Surface translocation of ACE2 and TMPRSS2 upon TLR4/7/8 activation is required for SARS-CoV-2 infection in circulating monocytes
Yao, Y., Subedi, K., Liu, T., Khalasawi, N., Pretto, C. D., Wotring, J. W., Wang, J., Yin, C., Jiang, A., Fu, C., et al. (2022) · Cell Discovery · doi:10.1038/s41421-022-00453-8 · Cited by 28
Targeted proteomics identifies circulating biomarkers associated with active COVID-19 and post-COVID-19
Zoodsma, M., de Nooijer, A., Grondman, I., Gupta, M. K., Bonifacius, A., Koeken, V. A. C. M., Kooistra, E. J., Kılıç, G., Bulut, O. P., Gödecke, N., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1027122 · Cited by 31
The JAK1/2 inhibitor ruxolitinib in patients with COVID-19 triggered hyperinflammation: the RuxCoFlam trial
Hammersen, J., Birndt, S., Döhner, K., Reuken, P. A., Stallmach, A., Sauerbrey, P., Rosée, F. L., Pfirrmann, M., Fabisch, C., Weiss, M., et al. (2023) · Leukemia · doi:10.1038/s41375-023-01979-w · Cited by 28
Emetine Is Not Ipecac: Considerations for Its Use as Treatment for SARS-CoV2
Bleasel, M. D., & Peterson, G. M. (2020) · Pharmaceuticals · doi:10.3390/ph13120428 · Cited by 29
mRNA COVID-19 vaccine elicits potent adaptive immune response without the persistent inflammation seen in SARS-CoV-2 infectionPreprint
Ivanova, E. N., Shwetar, J., Devlin, J. C., Buus, T. B., Gray-Gaillard, S. L., Koide, A., Cornelius, A. R., Samanovic, M. I., Herrera, A. M., Mimitou, E. P., et al. (2021) · medRxiv · doi:10.1101/2021.04.20.21255677 · Cited by 29
SARS-CoV-2 mutations in Brazil: from genomics to putative clinical conditions
Timmers, L. F. S. M., Peixoto, J. V., Ducati, R. G., Bachega, J. F. R., Pereira, L. D. M., Caceres, R. A., Majolo, F., da Silva, G. L., Anton, D. B., Dellagostin, O. A., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-91585-6 · Cited by 30
Phenolics and terpenoids with good anti-inflammatory activity from the fruits of Amomum villosum and the anti-inflammatory mechanism of active diterpene
Xu, Y., Sun, D., Xiong, L., Zhang, Z., Li, Y., Li, H., Li, H., & Chen, L. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107190 · Cited by 27
Therapeutic targeting of the host-microbiota-immune axis: implications for precision health
Nazir, A., Hussain, F. H. N., Hussain, T. H. N., Dweik, R. A., & Raza, A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1570233 · Cited by 31
COVID-19 and myeloid cells: complex interplay correlates with lung severity
D’Alessio, F. R., & Heller, N. M. (2020) · Journal of Clinical Investigation · doi:10.1172/jci143361 · Cited by 25
Correlation Between Early Plasma Interleukin 37 Responses With Low Inflammatory Cytokine Levels and Benign Clinical Outcomes in Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Li, A., Ling, Y., Song, Z., Cheng, X., Ding, L., Jiang, R.-D., Fu, W., Liu, Y., Hu, H., Yuan, S., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa713 · Cited by 27
Cytokine ranking via mutual information algorithm correlates cytokine profiles with presenting disease severity in patients infected with SARS-CoV-2
Huntington, K. E., Louie, A. D., Lee, C. G., Elias, J. A., Ross, E. A., & El‐Deiry, W. S. (2021) · eLife · doi:10.7554/elife.64958 · Cited by 27
Innate immune response analysis in COVID-19 and kawasaki disease reveals MIS-C predictors
Yang, C.-A., Huang, Y., & Chiang, B. (2021) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2021.06.009 · Cited by 28
Rapid generation of mouse model for emerging infectious disease with the case of severe COVID-19
Sun, C., Jan, J., Wang, I.-H., Ma, H., Ko, H., Wu, P., Kuo, T.-J., Liao, H.-N., Lan, Y.-H., Sie, Z., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009758 · Cited by 28
Meta-analysis of single-cell RNA-seq data reveals phenotypic switching of immune cells in severe COVID-19 patients
Hasan, M. Z., Islam, S., Matsumoto, K., & Kawai, T. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104792 · Cited by 28
Computational Analysis Illustrates the Mechanism of Qingfei Paidu Decoction in Blocking the Transition of COVID-19 Patients from Mild to Severe Stage
Chen, W., Li, X., Liu, X., Lin, Y., Tang, Q., & Meng, F. (2021) · Current Gene Therapy · doi:10.2174/1566523221666210907162005 · Cited by 27
Myeloid cells in COVID-19 microenvironment
Qin, G., Liu, S., Li, Y., Yu, W., & Zhang, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00792-0 · Cited by 27

Authors: Merad, M., & Martin, J. C.
Affiliations: Inserm (FR)
Corresponding author: Martin, Jerome C.
ORCID: Martin, Jerome C.
Venue: Nature Reviews Immunology
Publisher: Springer Science and Business Media LLC
Published: 2020-05-06
Volume: 20
Issue: 6
Pages: 355-362
ISSN: 1474-1733 (ISSN-L)
1474-1741
DOI: 10.1038/s41577-020-0331-4
PMC: PMC7201395
OpenAlex: W3023982717
Cited by: 2,472
References: 65
Citations by year: 2026: 89 · 2025: 133 · 2024: 196 · 2023: 330 · 2022: 529 · 2021: 753 · 2020: 435
FWCI: 24.29
Type: journal article
Language: en
Update notices: correction (2020-06-02)
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature reviews. Immunology (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
HAL (submittedVersion)
Funders: Icahn School of Medicine at Mount Sinai
Agence Nationale de la Recherche (ANR-16-IDEX-0007)
Institut National de la Santé et de la Recherche Médicale
Université de Nantes
Topics: Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Keywords: COVID-19 pandemic, SARS-CoV-2, monocytes, macrophages, hyperinflammation, macrophage activation syndrome, innate immunity, inflammatory signaling
MeSH terms: Betacoronavirus, COVID-19, SARS-CoV-2, Animals, Humans, Inflammation, Macrophage Activation, Macrophages, Monocytes, Pneumonia, Viral, Coronavirus Infections, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks